Popular searches: AAPL TSLA NVDA MSFT GOOGL

ATNM Stock Price Prediction 2026

Actinium Pharmaceuticals, Inc

$1.16
$-0.07 (-5.69%)

AI-powered price predictions based on fundamental analysis and growth projections

Last Updated: January 30, 2026
🎯
AI TRADING RECOMMENDATION
Evaluate position
Key Signals:
  • • MACD converging near zero line - potential energy building
  • • Volume showing distribution (CMF: -0.1488)
  • • Recent pattern: Doji - Indecision pattern
  • • Price near support at $1.22
MACD: Converging | Volume: Distribution
Fair Value Estimate
+244.8% Undervalued
Fair Value: $4.00 (Current: $1.16)

Based on PEG ratio analysis, this stock appears undervalued at current levels. The fair value estimate suggests 244.8% upside potential.

PEG Ratio
0.02
Attractive
Current P/E
6.84
Fair P/E
23.59
Earnings Growth
331.0%
📉

Volume Trend: Distribution

Selling Pressure Present - Distribution pattern observed

Chaikin Money Flow (CMF): -0.149
Money Flow Index (MFI): 30.6

Negative CMF indicates money flowing out of the stock. Exercise caution as this may signal distribution.

Price Targets by Timeframe
AI-based growth projections (not Wall Street analyst targets)
Timeframe Target Price Potential Return
30 Days $1.47 +26.5%
90 Days $2.12 +82.8%
6 Months $3.08 +165.5%
1 Year $5.00 +331.0%

More ATNM Analysis

Why is ATNM Moving? Buy or Sell ATNM? ATNM Full Analysis ATNM Trendline Analysis
ATNM Price Prediction Trendline

Scenario Analysis (1-Year Outlook)

Bull Case
30% Probability
$6.25 (+438.8%)

Best case scenario if strong fundamentals and market conditions align

Base Case
50% Probability
$5.00 (+331.0%)

Expected scenario based on current growth trajectory

Bear Case
20% Probability
$3.50 (201.7%)

Downside scenario if market headwinds or disappointing results

Technical Indicators

RSI (14)
37.4
Neutral
MACD Signal
Bearish
Trend
Downtrend
Money Flow (CMF)
-0.15

Key Fundamentals

Forward P/E
6.84
P/S Ratio (TTM)
402.08x
High Premium
Revenue Growth (QoQ)
-1.0%
Market Cap
$36M
Analyst Target
$5.00
52-Week High
$1.22
52-Week Low
$1.16
Investment Disclaimer: These price predictions are generated using AI models and historical data. They are not financial advice and should not be the sole basis for investment decisions. Past performance does not guarantee future results. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.
Buy or Sell Analysis Trendline Analysis Investment Advisor Options Advisor Options Chain & Analysis